EP 2870161 B1 20180808 - OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES FOR THE TREATMENT OF REPERFUSION INJURY
Title (en)
OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES FOR THE TREATMENT OF REPERFUSION INJURY
Title (de)
OXABICYCLOHEPTANE UND OXABICYCLOHEPTENE ZUR BEHANDLUNG VON REPERFUSIONSSCHÄDEN
Title (fr)
OXABICYCLOHEPTANES ET OXABICYCLOHEPTÈNES POUR LE TRAITEMENT D'UNE LÉSION DE REPERFUSION
Publication
Application
Priority
- US 201261666535 P 20120629
- US 201361782894 P 20130314
- US 2013048697 W 20130628
Abstract (en)
[origin: WO2014005080A1] A method of reducing reperfusion injury in mammalian tissue comprising contacting the tissue with a protein phosphatase 2A (PP2A) inhibitor having the structure.
IPC 8 full level
A61K 31/34 (2006.01); A61K 31/341 (2006.01); A61K 31/4178 (2006.01); A61K 31/443 (2006.01); A61K 31/4525 (2006.01); A61K 31/496 (2006.01); A61P 9/10 (2006.01); A61P 41/00 (2006.01); A61P 43/00 (2006.01); C07D 493/08 (2006.01)
CPC (source: CN EP US)
A61K 31/34 (2013.01 - CN EP US); A61K 31/341 (2013.01 - EP US); A61K 31/4178 (2013.01 - CN); A61K 31/443 (2013.01 - EP US); A61K 31/4525 (2013.01 - CN); A61K 31/496 (2013.01 - CN EP US); A61P 9/10 (2017.12 - EP); A61P 9/14 (2017.12 - EP); A61P 17/02 (2017.12 - EP); A61P 41/00 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2014005080 A1 20140103; CA 2876703 A1 20140103; CN 104619710 A 20150513; CN 104619710 B 20170922; EP 2870161 A1 20150513; EP 2870161 A4 20151223; EP 2870161 B1 20180808; HK 1209424 A1 20160401; JP 2015522032 A 20150803; JP 2018048178 A 20180329; JP 6262225 B2 20180117; US 2015174123 A1 20150625
DOCDB simple family (application)
US 2013048697 W 20130628; CA 2876703 A 20130628; CN 201380035527 A 20130628; EP 13808660 A 20130628; HK 15110175 A 20151016; JP 2015520594 A 20130628; JP 2017206285 A 20171025; US 201314408208 A 20130628